Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of NGL FINE CHM. For more details, see the NGL FINE CHM quarterly results and NGL FINE CHM share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 8.2 |
No. of shares | m | 6.18 |
1 Week | % | 4.8 |
1 Month | % | 20.7 |
1 Year | % | 83.7 |
52 week H/L | Rs | 2,425.1/1,293.7 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
NGL FINE CHM EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 662 | 620 | 1,785 | 3,789 | 2,569 | |
Low | Rs | 320 | 220 | 255 | 1,501 | 1,161 | |
Sales per share (Unadj.) | Rs | 247.9 | 245.4 | 417.4 | 513.8 | 450.0 | |
Earnings per share (Unadj.) | Rs | 32.6 | 13.5 | 91.8 | 80.7 | 33.2 | |
Diluted earnings per share | Rs | 32.6 | 13.5 | 91.8 | 80.8 | 33.2 | |
Cash flow per share (Unadj.) | Rs | 42.8 | 26.6 | 105.3 | 97.5 | 51.4 | |
Dividends per share (Unadj.) | Rs | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | |
Adj. dividends per share | Rs | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | |
Avg Dividend yield | % | 0.4 | 0.4 | 0.2 | 0.1 | 0.1 | |
Book value per share (Unadj.) | Rs | 149.1 | 160.1 | 249.9 | 328.8 | 360.1 | |
Adj. book value per share | Rs | 149.1 | 160.2 | 250.0 | 328.9 | 360.2 | |
Shares outstanding (eoy) | m | 6.18 | 6.18 | 6.18 | 6.18 | 6.18 | |
Price / Sales ratio | x | 2.0 | 1.7 | 2.4 | 5.1 | 4.1 | |
Avg P/E ratio | x | 15.1 | 31.1 | 11.1 | 32.8 | 56.2 | |
P/CF ratio (eoy) | x | 11.5 | 15.8 | 9.7 | 27.1 | 36.3 | |
Price / Book Value ratio | x | 3.3 | 2.6 | 4.1 | 8.0 | 5.2 | |
Dividend payout | % | 5.4 | 13.0 | 1.9 | 2.2 | 5.3 | |
Avg Mkt Cap | Rs m | 3,033 | 2,595 | 6,301 | 16,342 | 11,523 | |
Total wages/salary | Rs m | 212 | 240 | 281 | 349 | 369 |
NGL FINE CHM INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,532 | 1,517 | 2,580 | 3,175 | 2,781 | |
Other income | Rs m | 41 | 31 | 80 | 107 | 55 | |
Total revenues | Rs m | 1,573 | 1,547 | 2,660 | 3,282 | 2,836 | |
Gross profit | Rs m | 323 | 198 | 801 | 682 | 350 | |
Depreciation | Rs m | 63 | 81 | 83 | 104 | 113 | |
Interest | Rs m | 25 | 26 | 22 | 19 | 18 | |
Profit before tax | Rs m | 276 | 121 | 776 | 666 | 274 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 74 | 37 | 209 | 167 | 69 | |
Profit after tax | Rs m | 201 | 83 | 567 | 499 | 205 | |
Gross profit margin | % | 21.1 | 13.0 | 31.1 | 21.5 | 12.6 | |
Effective tax rate | % | 27.0 | 31.0 | 26.9 | 25.1 | 25.1 | |
Net profit margin | % | 13.1 | 5.5 | 22.0 | 15.7 | 7.4 |
NGL FINE CHM BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 864 | 809 | 1,245 | 1,735 | 1,627 | |
Current liabilities | Rs m | 452 | 430 | 418 | 657 | 583 | |
Net working cap to sales | % | 26.9 | 24.9 | 32.1 | 34.0 | 37.5 | |
Current ratio | x | 1.9 | 1.9 | 3.0 | 2.6 | 2.8 | |
Inventory Days | Days | 25 | 38 | 50 | 42 | 65 | |
Debtors Days | Days | 78,931,346 | 63,027,059 | 531 | 735 | 865 | |
Net fixed assets | Rs m | 628 | 728 | 829 | 1,034 | 1,244 | |
Share capital | Rs m | 31 | 31 | 31 | 31 | 31 | |
"Free" reserves | Rs m | 890 | 959 | 1,514 | 2,001 | 2,195 | |
Net worth | Rs m | 921 | 990 | 1,545 | 2,032 | 2,225 | |
Long term debt | Rs m | 80 | 83 | 61 | 34 | 21 | |
Total assets | Rs m | 1,492 | 1,536 | 2,074 | 2,769 | 2,871 | |
Interest coverage | x | 11.8 | 5.6 | 36.2 | 35.8 | 15.9 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.0 | 1.0 | 1.2 | 1.1 | 1.0 | |
Return on assets | % | 15.2 | 7.1 | 28.4 | 18.7 | 7.8 | |
Return on equity | % | 21.8 | 8.4 | 36.7 | 24.6 | 9.2 | |
Return on capital | % | 30.1 | 13.7 | 49.7 | 33.2 | 13.0 | |
Exports to sales | % | 76.9 | 72.1 | 75.5 | 73.2 | 74.3 | |
Imports to sales | % | 6.8 | 9.1 | 9.7 | 9.5 | 9.9 | |
Exports (fob) | Rs m | 1,178 | 1,094 | 1,947 | 2,325 | 2,066 | |
Imports (cif) | Rs m | 105 | 139 | 251 | 302 | 276 | |
Fx inflow | Rs m | 1,194 | 1,106 | 1,977 | 2,377 | 2,095 | |
Fx outflow | Rs m | 125 | 170 | 281 | 326 | 304 | |
Net fx | Rs m | 1,069 | 937 | 1,696 | 2,051 | 1,790 |
NGL FINE CHM CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 88 | 205 | 274 | 138 | 353 | |
From Investments | Rs m | -95 | -196 | -246 | -142 | -270 | |
From Financial Activity | Rs m | 0 | -13 | -11 | -11 | -11 | |
Net Cashflow | Rs m | -7 | -4 | 17 | -15 | 72 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Rahul J Nachane | COMP SEC: Pallavi Pednekar | YEAR OF INC: 1981 | BSE CODE: 524774 | FV (Rs): 5 | DIV YIELD (%): 0.1 |
Read: NGL FINE CHM 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare NGL FINE CHM With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.